Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
Deutsche Version Deutsche Version
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
Krebsforschung_EN.png
 
 
 
Hauptnavigation
  • Home
  • General Information
    • History
    • 50 years Institute for Cancer Research
    • Imagevideo: Institute for Cancer Research
  • Research
    • Research Focus
    • Research Laboratories
    • Scientific Services - Core Facilities
  • Teaching
    • Lectures of the Institute of Cancer Research
    • University Course Toxicology for Postgraduates
    • PhD Program Inflammation and Immunity
    • PhD Program IPPTO Translational Oncology
    • PhD Program Malignant Diseases
    • PhD Program Clinical and Experimental Oncology
  • Contact
    • Contact
    • Map
 
Research / Research Focus / Applied and Experimental Oncology / Klaus Holzmann
 
Subnavigation
  • Research Focus
    • Cellular and Molecular Tumorbiology
    • Applied and Experimental Oncology
      • Walter Berger
      • Martin Filipits
      • Petra Heffeter
      • Michael Grusch
      • Klaus Holzmann
        • Research Projects
        • Group Members
        • Former Group Members
        • Teaching
        • Short CV
      • Hedwig Sutterlüty
    • Chemical Safety and Cancer Prevention
    • Tumor Progression and Metastasis
  • Research Laboratories
  • Scientific Services - Core Facilities


Inhaltsbereich

 

Klaus Holzmann, Ao.Univ.-Prof. Dipl.-Ing. Dr.
Group Leader

E-Mail: klaus.holzmann [at] meduniwien [dot] ac [dot] at
Phone: +43 (0)1 40160 - 57530 (Office), 57535 (Lab)
Fax: +43 (0)1 40160 - 957500

Research Focus

The main focus of our research is analyses of two essential hallmarks of tumors, immortality and growth factor signaling. In detail, we study the telomere maintenance mechanisms (TMMs) and the fibroblast growth factor receptor (FGFR) signaling pathway. We aim to characterize the mechanism behind in various tumors and respective tumor cell models of human and canine origin. We aim to translate this knowledge into novel therapeutic strategies or combinations with established ones.

Financial support: Jubiläumsfonds der Österreichischen Nationalbank, Initiative Krebsforschung, Hochschuljubiläumsstiftung der Stadt Wien, Herzfelder Foundation, Fonds des Bürgermeisters der Bundeshauptstadt Wien

Group Members

Selected Publications

Prevalence and potentially prognostic value of C-circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma
Bicanova L, Kreilmeier-Berger T, Reifinger M, Holzmann K., Kleiter M.
Vet Comp Oncol. 2020 Nov 19. doi: 10.1111/vco.12665. PMID: 33211388

Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns.
Posch A, Hofer-Zeni S, Klieser E, Primavesi F, Naderlinger E, Brandstetter A, Filipits M, Urbas R, Swiercynski S, Jäger T, Winkelmann P, Kiesslich T, Lu L, Neureiter D, Stättner S, Holzmann K.
Cancers (Basel). 2020 Jun 19;12(6):E1625. doi: 10.3390/cancers12061625

Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer.
Holzmann K, Marian B.
Cells. 2019 Oct 2;8(10):1191. doi: 10.3390/cells8101191.

Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.
Naderlinger E, Holzmann K;
Genes (Basel). 2017 May 17;8(5). pii: E145. doi: 10.3390/genes8050145.

Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer.
Deloria AJ, Höflmayer D, Kienzl P, Łopatecka1 J, Sampl S, Klimpfinger M, Braunschmid T, Bastian F, Lu L, Marian B, Stättner S, Holzmann K;
Oncotarget. 2016 Nov 8;7(45):73800-73816. doi: 10.18632/oncotarget.12070.

Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T, Sampl S, Deloria AJ, Walter I, Reifinger M, Hauck M, Borst LB, Holzmann K, Kleiter M.; Mol Carcinog. 2016 Sep 1. doi: 10.1002/mc.22546.

LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines.
Aschacher T, Wolf B, Enzmann F, Kienzl P, Messner B, Sampl S, Svoboda M, Mechtcheriakova D, Holzmann K, Bergmann M.
Oncogene. 2016 Jan 7;35(1):94-104. doi: 10.1038/onc.2015.65.

Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis.
Heinzle C, Gsur A, Hunjadi M, Erdem Z, Gauglhofer C, Stättner S, Karner J, Klimpfinger M, Wrba F, Reti A, Hegedus B, Baierl A, Grasl-Kraupp B, Holzmann K, Grusch M, Berger W, Marian B.;
Cancer Res. 2012 Nov 15;72(22):5767-77. doi: 10.1158/0008-5472.CAN-11-3654.

The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations.
Aschacher T, Sampl S, Käser L, Bernhard D, Spittler A, Holzmann K, Bergmann M.;
Neoplasia. 2012 Jan;14(1):44-53.

Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade.
Sampl S, Pramhas S, Stern C, Preusser M, Marosi C, Holzmann K.;
Transl Oncol. 2012 Feb;5(1):56-65.

MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer.
Hofer P, Baierl A, Feik E, Führlinger G, Leeb G, Mach K, Holzmann K, Micksche M, Gsur A.;
Carcinogenesis. 2011 Jun;32(6):866-71. doi: 10.1093/carcin/bgr053.

Telomere Transcripts Target Telomerase in Human Cancer Cells.
Kreilmeier T, Mejri D, Hauck M, Kleiter M, Holzmann K;
Genes (Basel). 2016 Aug 16;7(8). pii: E46. doi: 10.3390/genes7080046.

 

 

All Publications

PubmedDatabase

 
Print
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact